Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current epidemiological overview of glomerulonephritis in Latin America: a systematic literature review.

Journal of nephrology·2025
Same author

Acute kidney injury in critically ill COVID-19 patients in a tertiary hospital: short and long-term kidney and patient outcomes.

Jornal brasileiro de nefrologia·2025
Same author

Epidemiological profile of kidney transplant patients with lupus nephritis.

Jornal brasileiro de nefrologia·2024
Same author

Kidney transplantation and perioperative complications: a prospective cohort study.

Brazilian journal of anesthesiology (Elsevier)·2024
Same author

Pregnancy after kidney transplantation: 40 years single-center experience.

Jornal brasileiro de nefrologia·2023
Same author

Real-world effectiveness and safety of direct-acting antivirals for the treatment of hepatitis C virus in kidney and liver transplant recipients: experience of a large transplant center in Brazil.

Revista do Instituto de Medicina Tropical de Sao Paulo·2023

Related Experiment Video

Updated: Jul 6, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Systemic hypertension and microalbuminuria.

Ana Maria Nunes de Faria Stamm1, Gisele Meinerz, Jacqueline Consuelo da Silva

  • 1Hospital Universitário Prof. Dr. Polydoro Ernani São Thiago, Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil. stamm@ativanet.com.br

Arquivos Brasileiros De Cardiologia
|March 5, 2008
PubMed
Summary

Microalbuminuria, a marker of kidney damage, affects 13.7% of treated hypertensive patients. It is significantly associated with target organ damage, especially cardiac lesions, in this population.

Related Experiment Videos

Last Updated: Jul 6, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Area of Science:

  • Cardiology
  • Nephrology
  • Hypertension Management

Background:

  • Hypertension is a major risk factor for cardiovascular and kidney disease.
  • Microalbuminuria indicates early kidney damage and is a predictor of cardiovascular events.
  • Identifying target organ lesions in hypertensive patients is crucial for risk stratification.

Purpose of the Study:

  • To determine the prevalence of microalbuminuria and target organ lesions in treated hypertensive patients.
  • To investigate the association between microalbuminuria and target organ lesions in this population.

Main Methods:

  • An observational, descriptive, cross-sectional study was conducted.
  • 153 hypertensive patients undergoing treatment were recruited from Internal Medicine and Cardiology Outpatient Clinics.
  • Data were collected between April and August 2006.

Main Results:

  • The prevalence of microalbuminuria was 13.7% (21/153).
  • The prevalence of target organ lesions was 48.4%, with cardiac lesions being the most common.
  • Target organ lesions were significantly more prevalent in patients with microalbuminuria (76.2%) compared to those without (43.9%) (p=0.006).

Conclusions:

  • A significant association exists between microalbuminuria and target organ lesions in treated hypertensive patients.
  • Microalbuminuria is particularly associated with cardiac lesions, even in the geriatric population.
  • These findings highlight the importance of screening for microalbuminuria in hypertensive patients to identify those at higher risk for target organ damage.